RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Monday reported a loss of $200,000 in its fourth quarter.
On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 14 cents.
The diagnostics company posted revenue of $1.9 million in the period.
For the year, the company reported that its loss narrowed to $6.7 million, or $3.48 per share. Revenue was reported as $7.3 million.
The company’s shares closed at $3.09. A year ago, they were trading at $5.03.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGIX at https://www.zacks.com/ap/CGIX
Please read our comment policy before commenting.